Tablets

Lupin Launches Atorvastatin Calcium Tablets USP

National, September 29, 2020: Pharma major Lupin Limited (Lupin) announced the launch of Atorvastatin Calcium Tablets USP, 10 mg, 20…

4 years ago

Lupin’s Alliance Partner Concord Receives U.S. FDA Approval for Mycophenolate Mofetil Tablets USP

New Delhi, August 07, 2020: Pharma major Lupin Limited (Lupin) in alliance with Concord Biotech Limited (Concord) announced that it…

4 years ago

Hydroxychloroquine and Chloroquine Marketto more than Double in 2020 – TechSci Research

Increase in prevalence of COVID-19 to drive demand for hydroxychloroquine and chloroquine across the globe New Delhi, April 29, 2020: According…

5 years ago

SIRIO Group introduces one-stop-platform for plant-based nutraceuticals at SupplySide West

In 2020 nutra brands will look to ensure they have plant-based options across all product classes – with many actively looking…

5 years ago

Dr. Reddy’s Laboratories announces the launch of Bupropion Hydrochloride Extended-Release Tablets, USP (SR)in the U.S. Market

Hyderabad, September 07, 2019: Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred…

5 years ago

Dr. Reddy’s Laboratories announces the launch of Ramelteon Tablets, in the U.S. Market

Hyderabad, July 23, 2019: Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DR REDDY, NYSE: RDY, along with its subsidiaries together…

5 years ago